ANP vs BNP vs CNP: How the Three Natriuretic Peptides Differ in the Record

Written by Research Editor · Reviewed by Physiology Literature Reviewer · Last updated: 2026-09-20
Independent research notes

This is a personal independent educational research site. All content consists of my personal study notes for academic reference only. It is NOT medical advice and cannot be used for disease diagnosis, treatment or clinical decision-making. This site is not affiliated with any peptide supplier or medical institution.

I keep three notebooks on the natriuretic peptides, and the one that fills fastest is the comparison set. ANP vs BNP vs CNP looks like a simple three-way table until you try to fill the cells from papers that were never designed to be read side by side.

This page is my working comparison. It records where each peptide comes from, how long the mature form is, which receptor it prefers and how quickly it clears. It is a reading aid and an archival record, not a clinical summary. See natriuretic peptide family notes.

Where the record disagrees, I say so. Most of the disagreement I have logged comes from mixed models, routes and assays rather than from any real conflict in the underlying biology.

Three genes, three expression sites

NPPA sits on human chromosome 1p36 and is expressed mainly in atrial cardiomyocytes, where the prohormone is stored in secretory granules and released under stretch. NPPB lies nearby and is expressed in both atria and ventricles, with ventricular expression rising sharply under wall stress. NPPC is the outlier of the set.

NPPC is expressed widely: endothelium, central nervous system, kidney and cartilage. In my notes that expression pattern explains most of the functional split. ANP and BNP are built to enter blood and act at a distance, while CNP behaves more like a local paracrine signal read near where it is made.

I also record which layer a paper worked on: transcript, stored prohormone, or circulating peptide. Mixing those layers inside a single comparison is another quiet source of disagreement in anp vs bnp vs cnp tables, and it is easy to miss because the peptide name stays the same at every layer.

Mature lengths and the conserved ring

Human ANP circulates as a 28-residue peptide, BNP as a 32-residue peptide, and CNP appears as 22- and 53-residue forms depending on processing. The lengths matter less than the ring: all three carry a 17-residue disulfide-bridged ring that is the conserved core of the family.

When I read an anp vs bnp vs cnp table I check first whether the quoted lengths refer to the mature circulating peptide or to a precursor form. That single ambiguity accounts for a large share of the mismatched figures in my early notes, and it is easy to miss in a review. Fuller detail sits in the ANP pages I keep.

Receptor preference and second messengers

ANP and BNP both prefer NPR-A, a membrane guanylyl cyclase that raises intracellular cGMP. CNP prefers NPR-B, a second cyclase with the same second messenger but a different tissue distribution. All three peptides also bind NPR-C, which removes them rather than signalling through cGMP.

The clearance receptor is the part I find skipped most often. A peptide that binds NPR-C well can look weaker in vivo than in vitro purely because it is being removed faster, and the anp vs bnp vs cnp literature does not always separate those two effects in its conclusions.

Circulating kinetics and clearance

Clearance is where the three diverge in practice rather than in principle. ANP is short-lived in plasma, BNP persists longer, and CNP is largely a local signal whose plasma values are hard to interpret without a tissue context. Receptor-mediated removal and peptidase susceptibility both contribute here.

I record kinetics as ranges with the assay named, never as one number. Estimates in my notes span more than tenfold depending on species, sampling site and whether the assay reads the intact peptide or a fragment of it. See the ANP research record I keep.

Why the literature splits: BNP in clinics, ANP in physiology

The split in the record is a history of measurement, not a judgement of importance. BNP and its N-terminal fragment became standard cardiac biomarkers because they are stable in a collected sample and run on automated analysers. ANP had a deeper mechanistic record before that infrastructure existed, so the receptor and clearance work is richer for ANP.

A search on anp vs bnp vs cnp therefore returns biomarker papers for BNP and mechanism papers for ANP. Reading those as if they answered the same question was the most common error in my own early notes, and it still appears in review tables I check.

The consequence for an archive like mine is a filing problem rather than a scientific one. I keep the biomarker literature and the physiology literature in separate runs of notes, then place them side by side only where a study measured more than one analyte in the same samples.

Holding model, route and assay constant

A three-way comparison only survives if the variables are pinned. Species changes the sequence, the route changes the exposure profile, and the assay decides whether you are reading the intact peptide or a fragment. Change two of these at once and the comparison stops carrying information about the peptides themselves.

My working rule is to compare only within one study when I can, and to mark rows absent rather than borrow values across studies. That makes the tables sparser and slower to build, but it keeps an ANP vs BNP vs CNP reading honest when I come back to it a year later. See editorial notes.

References

  1. PubMed search: NPPA NPPB NPPC gene structure and tissue expression
  2. PubMed search: natriuretic peptide receptor NPR-A NPR-B NPR-C function
  3. PubMed search: BNP NT-proBNP analytical stability and assay comparison
  4. PubMed search: ANP BNP CNP clearance neprilysin receptor mediated removal

References are recorded as text. The record links to no external domain: each entry can be re-run in any public bibliographic database.

Frequently Asked Questions

Why do anp vs bnp vs cnp tables look so inconsistent?

Because the cells usually come from different experiments. Species, route, sampling site and assay differ from paper to paper, and those variables move the numbers more than the peptides themselves do. I rebuild the comparison inside a single study whenever one is available. Where a study reports only one peptide, I mark the row absent rather than borrowing a value from elsewhere. That practice makes my tables sparser, but it keeps them readable and it is the main reason I keep a comparison set at all.

Which receptor does each natriuretic peptide prefer?

ANP and BNP both act mainly through NPR-A, CNP acts mainly through NPR-B, and all three are bound and internalised by NPR-C, which removes them from the circulation. NPR-A and NPR-B are membrane guanylyl cyclases that raise intracellular cGMP. NPR-C does not signal through cGMP in the same way and functions mostly as a clearance route. I also note receptor abundance in the tissue under study, because that changes which peptide appears dominant in a given preparation.

Why does BNP dominate the biomarker literature rather than ANP?

Stability and platform. The N-terminal fragment of BNP is stable in a collected sample and runs on automated analysers, which made it practical for routine cardiac measurement and for large clinical cohorts. ANP had a deeper mechanistic record but a shorter plasma life and a fragment profile that is harder to read in a stored sample. The dominance of BNP therefore reflects assay engineering and clinical workflow rather than a judgement that ANP is less interesting physiologically.

Do the three peptides share the same functions?

They overlap, but they are not identical and I do not substitute one for another. All three raise cGMP in target cells and act on kidney and vasculature, and CNP has an additional well documented role in endochondral bone growth. Potency, tissue weighting and clearance differ enough that a shared label can mislead. Where a paper reports a family-wide effect, I still check which peptide was actually used, because early literature often generalised from one member to all three.

PB
Research Editor
Compiled and maintained by the editorial desk. Every note here is traced back to a public source or a public discussion thread, and limitation statements travel with the claims they qualify.
Reviewed by Physiology Literature Reviewer · Last updated: 2026-09-20

Question about how this archive is compiled? The editorial desk answers questions about sources, attribution and correction requests.